Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.

about

Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes Immunological landscape of consensus clusters in colorectal cancer.Immunotherapeutic interventions of Triple Negative Breast Cancer.

P2860

Q36425747-93572DD9-2DD2-4012-AA2C-14281DF2115B Q47148210-DC8A543F-8DA8-423F-BBAD-F11A17838239 Q55257180-1D4A5BF2-623E-42CB-9BDF-0A40AD40FAF6

P2860

Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.

Item

http://www.wikidata.org/entity/Q38336989

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Mechanisms of tumor-induced T ...... tics to counter those effects.

@en

type

Item

label

Mechanisms of tumor-induced T ...... tics to counter those effects.

@en

prefLabel

Mechanisms of tumor-induced T ...... tics to counter those effects.

@en

P1476

Mechanisms of tumor-induced T ...... tics to counter those effects.

@en

P2093

Inkyu Hwang

http://www.w3.org/2001/XMLSchema#string

Nguyet Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

Prevention of allogeneic fetal rejection by tryptophan catabolism

Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

P2888

s12272-015-0566-y

P304

1415-1433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-015-0566-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031896600

http://www.w3.org/2001/XMLSchema#string

P698

25634101

http://www.w3.org/2001/XMLSchema#string

Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.

about

P2860

P2860

Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698